Atlas Venture Fund Vi Gmbh & Co Kg - Net Worth and Insider Trading

Atlas Venture Fund Vi Gmbh & Co Kg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Atlas Venture Fund Vi Gmbh & Co Kg owns 4 companies in total, including Carbon Black Inc (CBLK) , Horizon Therapeutics PLC (HZNP) , and Alnylam Pharmaceuticals Inc (ALNY) among others .

Click here to see the complete history of Atlas Venture Fund Vi Gmbh & Co Kg’s form 4 insider trades.

Insider Ownership Summary of Atlas Venture Fund Vi Gmbh & Co Kg

Ticker	Comapny	Transaction Date	Type of Owner
CBLK	Carbon Black Inc	2018-05-08	10 percent owner
HZNP	Horizon Therapeutics PLC	2012-03-02	10 percent owner
ALNY	Alnylam Pharmaceuticals Inc	2004-05-27	10 percent owner
		2005-08-03	10 percent owner

Atlas Venture Fund Vi Gmbh & Co Kg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Atlas Venture Fund Vi Gmbh & Co Kg Ownership Network

Ownership Network List of Atlas Venture Fund Vi Gmbh & Co Kg

No Data

Ownership Network Relation of Atlas Venture Fund Vi Gmbh & Co Kg

Atlas Venture Fund Vi Gmbh & Co Kg Owned Company Details

What does Carbon Black Inc do?

Who are the key executives at Carbon Black Inc?

Atlas Venture Fund Vi Gmbh & Co Kg is the 10 percent owner of Carbon Black Inc. Other key executives at Carbon Black Inc include See Remarks Mark P. Sullivan , 10 percent owner Highland Capital Partners Vi Lp , and 10 percent owner Highland Management Partners Vi L P .

Carbon Black Inc (CBLK) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Carbon Black Inc (CBLK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Carbon Black Inc (CBLK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Carbon Black Inc (CBLK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Carbon Black Inc Insider Transactions

No Available Data

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

Atlas Venture Fund Vi Gmbh & Co Kg is the 10 percent owner of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Horizon Therapeutics PLC Insider Transactions

No Available Data

What does Alnylam Pharmaceuticals Inc do?

Who are the key executives at Alnylam Pharmaceuticals Inc?

Atlas Venture Fund Vi Gmbh & Co Kg is the 10 percent owner of Alnylam Pharmaceuticals Inc. Other key executives at Alnylam Pharmaceuticals Inc include EVP & Chief Commercial Officer Yvonne Greenstreet , EVP & Chief Commercial Officer Tolga Tanguler , and CMO & EVP Dev & Med Affairs Pushkal Garg .

Alnylam Pharmaceuticals Inc (ALNY) Insider Trades Summary

Over the past 18 months, Atlas Venture Fund Vi Gmbh & Co Kg made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 52,531 shares made by Yvonne Greenstreet , a net sale of 10,304 shares made by Pushkal Garg , and a net sale of 5,639 shares made by Jeffrey V. Poulton .

In summary, during the past 3 months, insiders sold 15,000 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 15,000 shares. During the past 18 months, 249,128 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 249,128 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alnylam Pharmaceuticals Inc Insider Transactions

No Available Data

What does Momenta Pharmaceuticals Inc do?

Who are the key executives at Momenta Pharmaceuticals Inc?

Atlas Venture Fund Vi Gmbh & Co Kg is the 10 percent owner of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief Legal Officer Alejandra Carvajal , Chief Scientific Officer Anthony M. Manning , and SVP & Chief Medical Officer Santiago Arroyo .

Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Momenta Pharmaceuticals Inc Insider Transactions

No Available Data

Atlas Venture Fund Vi Gmbh & Co Kg Mailing Address

Above is the net worth, insider trading, and ownership report for Atlas Venture Fund Vi Gmbh & Co Kg. You might contact Atlas Venture Fund Vi Gmbh & Co Kg via mailing address: 890 Winter Street, Suite 320, Waltham Ma 02451.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.